EP 1109565 A4 20040519 - GABAB1AA RECEPTOR
Title (en)
GABAB1AA RECEPTOR
Title (de)
GABAB1AA REZEPTOR
Title (fr)
RECEPTEUR DE GABAB1AA
Publication
Application
Priority
- US 9919435 W 19990830
- US 14477998 A 19980901
Abstract (en)
[origin: WO0012106A1] The GABAB1AA polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing GABAB1AA polypeptides and polynucleotides in therapy, and diagnostic assays for such.
IPC 1-7
IPC 8 full level
A61K 31/711 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/04 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 9/02 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/06 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); A61P 19/10 (2006.01); A61P 25/04 (2006.01); A61P 25/16 (2006.01); A61P 25/22 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 37/08 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/31 (2006.01); C12P 21/02 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 33/577 (2006.01); G01N 33/58 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 3/04 (2017.12); A61P 3/10 (2017.12); A61P 9/02 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 11/06 (2017.12); A61P 13/02 (2017.12); A61P 15/00 (2017.12); A61P 19/10 (2017.12); A61P 25/04 (2017.12); A61P 25/16 (2017.12); A61P 25/22 (2017.12); A61P 31/00 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 37/08 (2017.12); C07K 14/70571 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01)
Citation (search report)
- [XY] WO 9746675 A1 19971211 - CIBA GEIGY AG [CH], et al
- [E] WO 9951636 A2 19991014 - NPS PHARMA INC [US], et al
- [E] WO 9961606 A1 19991202 - US HEALTH [US], et al
- [XY] DATABASE EMBL [online] 4 September 1997 (1997-09-04), "Homo sapiens mRNA for GABA-BR1a (hGB1a) receptor", XP002274177, retrieved from EBI Database accession no. Y11044 & GRIFA A. ET AL: "GABA (Gamma-Amino-Butyrc Acid) Neurotransmission: Identification and Fine Mapping of the Human GABA-B Receptor Gene", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 250, 18 September 1998 (1998-09-18), pages 240 - 245
- [XY] DATABASE EMBL [online] 16 November 1998 (1998-11-16), "Homo sapiens mRNA for GABA-B R1a receptor", XP002274178, retrieved from EBI Database accession no. AJ225028 & KAUPMANN K. ET AL.: "Human Gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwadly rectifying K+ channels", PROC. NATL. ACAD. SCI. USA, vol. 95, December 1998 (1998-12-01), pages 14991 - 14996, XP000867019
- [XY] DATABASE EMBL [online] 16 October 2001 (2001-10-16), "Gamma-aminobutyric acid type B receptor, subunit 1 precursor (GABA-B receptor 1) (GABA-B-R1) (Gb1)", XP002274179, retrieved from EBI Database accession no. Q9WV18
- [Y] BOWERY N G: "Metabotropic GABAB receptors cloned at last", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 18, no. 4, 1 April 1997 (1997-04-01), pages 103, XP004058669, ISSN: 0165-6147
- [A] KERR D I B ET AL: "GABABETA RECEPTORS", PHARMACOLOGY AND THERAPEUTICS, ELSEVIER, GB, vol. 67, no. 2, 1995, pages 187 - 246, XP002916277, ISSN: 0163-7258
- See references of WO 0012106A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0012106 A1 20000309; EP 1109565 A1 20010627; EP 1109565 A4 20040519; JP 2002523070 A 20020730
DOCDB simple family (application)
US 9919435 W 19990830; EP 99943923 A 19990830; JP 2000567222 A 19990830